Development of Novel Regimens Combining Immune Checkpoint Inhibitors and Radiation Therapy in Prostate Cancer

被引:0
作者
Swami, Umang [1 ]
Sayegh, Nicolas [1 ]
Agarwal, Neeraj [1 ]
机构
[1] Univ Utah, Huntsman Canc Inst, 2000 Circle Hope Dr, Salt Lake City, UT 84112 USA
关键词
RADIOTHERAPY; IPILIMUMAB; MULTICENTER; PLACEBO;
D O I
10.1016/j.eururo.2021.11.024
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
引用
收藏
页码:263 / 265
页数:3
相关论文
共 9 条
  • [1] Final Analysis of the Ipilimumab Versus Placebo Following Radiotherapy Phase III Trial in Postdocetaxel Metastatic Castration-resistant Prostate Cancer Identifies an Excess of Long-term Survivors
    Fizazi, Karim
    Drake, Charles G.
    Beer, Tomasz M.
    Kwon, Eugene D.
    Scher, Howard, I
    Gerritsen, Winald R.
    Bossi, Alberto
    van den Eertwegh, Alfons J. M.
    Krainer, Michael
    Houede, Nadine
    Santos, Ricardo
    Mahammedi, Hakim
    Ng, Siobhan
    Danielli, Riccardo
    Franke, Fabio A.
    Sundar, Santhanam
    Agarwal, Neeraj
    Bergman, Andre M.
    Ciuleanu, Tudor E.
    Korbenfeld, Ernesto
    Sengelov, Lisa
    Hansen, Steinbjorn
    McHenry, M. Brent
    Chen, Allen
    Logothetis, Christopher
    [J]. EUROPEAN UROLOGY, 2020, 78 (06) : 822 - 830
  • [2] A Phase lb Study of Atezolizumab with Radium-223 Dichloride in Men with Metastatic Castration-Resistant Prostate Cancer
    Fong, Lawrence
    Morris, Michael J.
    Sartor, Oliver
    Higano, Celestia S.
    Pagliaro, Lance
    Alva, Ajjai
    Appleman, Leonard J.
    Tan, Winston
    Vaishampayan, Ulka
    Porcu, Raphaelle
    Tayama, Darren
    Kadel, Edward E., III
    Yuen, Kobe C.
    Datye, Asim
    Armstrong, Andrew J.
    Petrylak, Daniel P.
    [J]. CLINICAL CANCER RESEARCH, 2021, 27 (17) : 4746 - 4756
  • [3] Avelumab Combined with Stereotactic Ablative Body Radiotherapy in Metastatic Castration-resistant Prostate Cancer: The Phase 2 ICE-PAC Clinical Trial
    Kwan, Edmond M.
    Spain, Lavinia
    Anton, Angelyn
    Gan, Chun L.
    Garrett, Linda
    Chang, Deborah
    Liow, Elizabeth
    Bennett, Caitlin
    Zheng, Tiantian
    Yu, Jianjun
    Dai, Chao
    Du, Pan
    Jia, Shidong
    Fettke, Heidi
    Abou-Seif, Claire
    Kothari, Gargi
    Shaw, Mark
    Parente, Phillip
    Pezaro, Carmel
    Tran, Ben
    Siva, Shankar
    Azad, Arun A.
    [J]. EUROPEAN UROLOGY, 2022, 81 (03) : 253 - 262
  • [4] Ipilimumab versus placebo after radiotherapy in patients with metastatic castration-resistant prostate cancer that had progressed after docetaxel chemotherapy (CA184-043): a multicentre, randomised, double-blind, phase 3 trial
    Kwon, Eugene D.
    Drake, Charles G.
    Scher, Howard I.
    Fizazi, Karim
    Bossi, Alberto
    van den Eertwegh, Alfons J. M.
    Krainer, Michael
    Houede, Nadine
    Santos, Ricardo
    Mahammedi, Hakim
    Siobhan Ng
    Maio, Michele
    Franke, Fabio A.
    Sundar, Santhanam
    Agarwal, Neeraj
    Bergman, Andries M.
    Ciuleanu, Tudor E.
    Korbenfeld, Ernesto
    Sengelov, Lisa
    Hansen, Steinbjorn
    Logothetis, Christopher
    Beer, Tomasz M.
    McHenry, M. Brent
    Gagnier, Paul
    Liu, David
    Gerritsen, Winald R.
    [J]. LANCET ONCOLOGY, 2014, 15 (07) : 700 - 712
  • [5] Radiobiology of stereotactic ablative radiotherapy (SABR): perspectives of clinical oncologists
    Li, Shan
    Shen, Liangfang
    [J]. JOURNAL OF CANCER, 2020, 11 (17): : 5056 - 5068
  • [6] A pilot trial of pembrolizumab plus prostatic cryotherapy for men with newly diagnosed oligometastatic hormone-sensitive prostate cancer
    Ross, Ashley E.
    Hurley, Paula J.
    Tran, Phuoc T.
    Rowe, Steven P.
    Benzon, Benjamin
    Neal, Tanya O'
    Chapman, Carolyn
    Harb, Rana
    Milman, Yelena
    Trock, Bruce J.
    Drake, Charles G.
    Antonarakis, Emmanuel S.
    [J]. PROSTATE CANCER AND PROSTATIC DISEASES, 2020, 23 (01) : 184 - 193
  • [7] The Next Decade of Immune Checkpoint Therapy
    Sharma, Padmanee
    Siddiqui, Bilal A.
    Anandhan, Swetha
    Yadav, Shalini S.
    Subudhi, Sumit K.
    Gao, Jianjun
    Goswami, Sangeeta
    Allison, James P.
    [J]. CANCER DISCOVERY, 2021, 11 (04) : 838 - 857
  • [8] Ipilimumab alone or in combination with radiotherapy in metastatic castration-resistant prostate cancer: results from an open-label, multicenter phase I/II study
    Slovin, S. F.
    Higano, C. S.
    Hamid, O.
    Tejwani, S.
    Harzstark, A.
    Alumkal, J. J.
    Scher, H. I.
    Chin, K.
    Gagnier, P.
    McHenry, M. B.
    Beer, T. M.
    [J]. ANNALS OF ONCOLOGY, 2013, 24 (07) : 1813 - 1821
  • [9] Immune Checkpoint Inhibitors in Prostate Cancer
    Venkatachalam, Shobi
    McFarland, Taylor R.
    Agarwal, Neeraj
    Swami, Umang
    [J]. CANCERS, 2021, 13 (09)